Advances in Hematological Malignancies
Recent centuries have witnessed remarkable strides in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative approaches, offering hope for more effective treatm